{
  "retracted": false,
  "timestamp": 1547769600000,
  "updates": [
    {
      "timestamp": 1585197897209,
      "identifier": {
        "doi": "10.1038/s41397-019-0073-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/tpj.2017.37"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab"
}
